Regional brain metabolism in schizophrenia: An FDG-PET study

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Schizophrenia is a complex psychiatric disorder with established biological underpinnings.
• Functional neuroimaging, particularly FDG-PET, is crucial for investigating the neurobiology of schizophrenia.

Purpose of the Study:

• To investigate cerebral glucose metabolism in patients with schizophrenia using FDG-PET.
• To explore the relationship between schizophrenia subtypes (positive vs. negative) and glucose metabolism.

Main Methods:

• FDG-PET scans were performed on 18 male patients with active psychosis due to schizophrenia.
• Glucose uptake was measured in various brain regions under resting conditions.
• Analysis focused on differences across the schizophrenia spectrum.

Main Results:

• No significant influence of illness chronicity or severity on cerebral glucose metabolism was found.
• Negative schizophrenia patients exhibited significantly decreased metabolism across all brain regions compared to positive schizophrenia patients.
• Positive schizophrenia was associated with significantly increased metabolism in the medial temporal regions, basal ganglia, and left thalamus; hypometabolism was observed in the cerebellum.

Conclusions:

• Distinct patterns of cerebral glucose metabolism differentiate schizophrenia subtypes.
• Specific brain regions show altered metabolism in positive and negative schizophrenia syndromes.
• The heterogeneity of schizophrenia presents challenges in precisely defining its disease process despite identified brain region involvement.